[1]
I. Costa, J. Reis, S. Meireles, M. J. Ribeiro, I. Augusto, and M. Barbosa, “Metastatic Castration-Resistant Prostate Cancer with BRCA2 Mutation: The Challenge Incorporating PARP Inhibitors and Platinum in Treatment Sequencing”, EJCRIM, vol. 9, no. 5, May 2022.